<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02762162</url>
  </required_header>
  <id_info>
    <org_study_id>ONASSIST</org_study_id>
    <nct_id>NCT02762162</nct_id>
  </id_info>
  <brief_title>Registry of Coronary Artery Ill Patients With Platelet Test Results</brief_title>
  <acronym>ONASSIST</acronym>
  <official_title>Online Assistance for Stent Thrombosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Action, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Action, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      ONASSIST is a registry of coronary ill patients who have had a functional test measuring
      anti-platelet effect and/or a genetic profile of response to anti-platelet drugs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Onassist Project is an assistance for cardiologists that establishes an individual risk
      of stent thrombosis for each patient based on:

        -  a functional approach (evaluation of the antiplatelet effect of the antiplatelet regimen
           by multiple tests) and

        -  a pharmacogenomic approach (genetic profile of response to antiplatelet agents) It
           provides advices for specific therapeutics after identification of adverse drug
           interactions, treatment compliance issues and true genetic, functional or mixed
           resistance.

      This individualized strategy allow to adjust the choice of the drugs and their optimal dosage
      considering the best benefit - risk ratio.

      Follow up are regularly made to identify markers of MACE (major adverse cardiac event) or
      bleeding.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Anticipated">January 2037</completion_date>
  <primary_completion_date type="Anticipated">January 2027</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Bleeding</measure>
    <time_frame>10 years</time_frame>
    <description>all bleeding according to the BARC (Bleeding Academic Research Consortium) definitions are registered during the follow up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Urgent Revascularization</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Resuscitated Cardiac Arrest</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Percutaneous Coronary Intervention</condition>
  <condition>Myocardial Infarction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        coronary ill patients who have had a functionnal test mesuring antiplatelet effect and / or
        a genetic profile of response to antiplatelet drugs.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  coronary disease

          -  antiplatelets testing performed as part of usual care and / or gentic profile of
             antiplatelet response done

        Exclusion Criteria:

          -  patient refusing to be part of the registry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean Philippe COLLET, MD, PhD</last_name>
    <phone>+33142162962</phone>
    <email>jean-philippe.collet@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Delphine Brugier, PhD</last_name>
    <phone>+33142162918</phone>
    <email>delphine.brugier-ext@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2016</study_first_submitted>
  <study_first_submitted_qc>May 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2016</study_first_posted>
  <last_update_submitted>May 30, 2016</last_update_submitted>
  <last_update_submitted_qc>May 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>antiplatelet</keyword>
  <keyword>stent thrombosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

